SYGNIS AG to attend upcoming Investor Conferences
(Thomson Reuters ONE) -
SYGNIS AG /
SYGNIS AG to attend upcoming Investor Conferences
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Madrid/Heidelberg, 7 November 2013 - SYGNIS AG (Frankfurt: LIO1; ISIN:
DE000A1RFM03; Prime Standard segment of the German Stock Exchange), the DNA
amplification and sequencing company, announced today the attendance at two
major German investor conferences in November and December 2013.
German Equity Forum hosted by Deutsche Börse AG
Date of Attendance: 12 and 13 November 2013
Venue: Frankfurt/Main, Germany, Congress Center
Attending and available for meetings: Pilar de la Huerta, CEO/CFO
More information: http://www.eigenkapitalforum.com/
16. Munich Capital Markets Conference hosted by GBC AG
Date of presentation: 04 December 2013, 15:10 - 15:50 pm CET
Venue: Munich, Germany, Sofitel Hotel, Room GBC III
Presentation at the MC Services HealthCare Forum and available for meetings:
Pilar de la Huerta, CEO/CFO
More information: http://www.mkk-investor.de/
If you like to meet us please contact for both conferences: contact(at)mc-
services.eu or via phone: +49 89 210 228-0.
For further information please contact:
SYGNIS AG
Pilar de la Huerta, CEO/CFO
Tel: +34-918063089
Email: pdelahuerta(at)sygnis.es
About SYGNIS AG: www.sygnis.com
After the merger in 2012 between X-Pol Biotech, specialising in DNA
amplification and sequencing, and SYGNIS AG, listed in the German Stock Exchange
(Prime Standard segment, Tick: LIO1; ISIN: DE000A1RFM03), SYGNIS' new mission is
to develop and distribute technologies and products from X-Pol, which has a
commercial product in the DNA amplification segment, QualiPhi(®) and is
currently developing other products in the field of Next Generation Sequencing.
### Disclaimer
This publication is intended for information only and constitutes neither an
offer to sell nor an invitation to buy securities. Some statements included in
this press release, relating neither to proven financial results nor other
historical data, should be viewed as forward-looking, i.e. not definite. Such
statements are mainly predictions of future results, trends, plans or goals.
These statements should not be considered to be total guarantees since given
their very nature they are subject to known and unknown risks and
imponderability and can be affected by other factors as a consequence of which
the actual results, plans and goals of SYGNIS AG may deviate greatly from the
established conclusions or implied predictions contained in such statements.
SYGNIS does not undertake to publicly update or revise these statements in the
light of new information or future results or for any other reason.###
Press Release (PDF):
http://hugin.info/150277/R/1741397/585078.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: SYGNIS AG via Thomson Reuters ONE
[HUG#1741397]
Unternehmensinformation / Kurzprofil:
Datum: 07.11.2013 - 10:00 Uhr
Sprache: Deutsch
News-ID 313801
Anzahl Zeichen: 3736
contact information:
Town:
Heidelberg
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 160 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SYGNIS AG to attend upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
SYGNIS AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
